Cowen and Company’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,964,127
| Closed | -$18.4M | – | 574 |
|
|
2024
Q2 | $18.4M | Sell |
2,964,127
-749,807
| -20% | -$4.65M | 0.51% | 26 |
|
|
2024
Q1 | $35.1M | Buy |
3,713,934
+240,000
| +7% | +$2.27M | 1.36% | 11 |
|
|
2023
Q4 | $23.4M | Sell |
3,473,934
-834,425
| -19% | -$5.63M | 1.54% | 18 |
|
|
2023
Q3 | $19.1M | Buy |
4,308,359
+1,191,363
| +38% | +$5.29M | 1.34% | 17 |
|
|
2023
Q2 | $10.3M | Buy |
3,116,996
+940,951
| +43% | +$3.11M | 0.85% | 28 |
|
|
2023
Q1 | $6.2M | Buy |
2,176,045
+814,876
| +60% | +$2.32M | 0.73% | 30 |
|
|
2022
Q4 | $9.91M | Sell |
1,361,169
-986,820
| -42% | -$7.18M | 1.04% | 20 |
|
|
2022
Q3 | $19M | Sell |
2,347,989
-37,896
| -2% | -$307K | 1.82% | 17 |
|
|
2022
Q2 | $11.7M | Sell |
2,385,885
-1,067,486
| -31% | -$5.23M | 1.13% | 26 |
|
|
2022
Q1 | $81.7M | Buy |
+3,453,371
| New | +$81.7M | 7.86% | 1 |
|
|
2021
Q4 | – | Sell |
-1,560,563
| Closed | -$44M | – | 522 |
|
|
2021
Q3 | $44M | Buy |
1,560,563
+240,676
| +18% | +$6.79M | 2.09% | 12 |
|
|
2021
Q2 | $13.8M | Buy |
1,319,887
+438,055
| +50% | +$4.59M | 0.72% | 25 |
|
|
2021
Q1 | $10.4M | Buy |
+881,832
| New | +$10.4M | 0.71% | 15 |
|